| Title : Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates - Hackett_2005_Hum.Gene.Ther_16_1484 |
| Author(s) : Hackett NR , Redmond DE , Sondhi D , Giannaris EL , Vassallo E , Stratton J , Qiu J , Kaminsky SM , Lesser ML , Fisch GS , Rouselle SD , Crystal RG |
| Ref : Hum Gene Therapy , 16 :1484 , 2005 |
| Abstract : Hackett_2005_Hum.Gene.Ther_16_1484 |
| ESTHER : Hackett_2005_Hum.Gene.Ther_16_1484 |
| PubMedSearch : Hackett_2005_Hum.Gene.Ther_16_1484 |
| PubMedID: 16390279 |
Hackett NR, Redmond DE, Sondhi D, Giannaris EL, Vassallo E, Stratton J, Qiu J, Kaminsky SM, Lesser ML, Fisch GS, Rouselle SD, Crystal RG (2005)
Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates
Hum Gene Therapy
16 :1484
Hackett NR, Redmond DE, Sondhi D, Giannaris EL, Vassallo E, Stratton J, Qiu J, Kaminsky SM, Lesser ML, Fisch GS, Rouselle SD, Crystal RG (2005)
Hum Gene Therapy
16 :1484